Induced pluripotent stem cells mediate the release of interferon gamma-induced protein 10 and alleviate bleomycin-induced lung inflammation and fibrosis

Shock

Volumn 39, Issue 3, 2013, Pages 261-270

  How, Chorng Kuang ^a,b   Chien, Yueh ^a,b   Yang, Kuang Yao ^a,b   Shih, Hsin Chin ^a,b   Juan, Chi Chang ^a   Yang, Yi Ping ^a,b   Chiou, Guang Yuh ^a,b   Huang, Pin I ^a,b   Chang, Yuh Lih ^a,b   Chen, Liang Kung ^a,b   Wang, Chien Ying ^a,b   Hsu, Han Shui ^a   Chiou, Shih Hwa ^a,b   Lee, Chen Hsen ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Bleomycin; conditioned medium; induced pluripotent stem cells; lung fibrosis

Indexed keywords

BLEOMYCIN; COLLAGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NEUTRALIZING ANTIBODY; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BIOACCUMULATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATORY CELL; INHIBITION KINETICS; LUNG FIBROSIS; LUNG FUNCTION; MOUSE; NEUTROPHIL; NONHUMAN; OSTEOCYTE; PLURIPOTENT STEM CELL; PNEUMONIA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; STEM CELL TRANSPLANTATION;

ANIMALS; BLEOMYCIN; CHEMOKINE CXCL10; CULTURE MEDIA, CONDITIONED; CYTOKINES; DISEASE MODELS, ANIMAL; GENES, MYC; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; PEROXIDASE; PNEUMONIA; PULMONARY FIBROSIS;

EID: 84874280704     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318285f2e2     Document Type: Article

References (33)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 342(18):1334-1349, 2000.
2. Perez A, Rogers RM, Dauber JH: The prognosis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 29(Suppl 3):S19-S26, 2003.
3. Strieter RM, Mehrad B: New mechanisms of pulmonary fibrosis. Chest 136(5):1364-1370, 2009.
4. Moore BB, Hogaboam CM: Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294(2):L152-L160, 2008.
5. Matute-Bello G, Frevert CW, Martin TR: Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295(3):L379-L399, 2008.
6. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A: Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 175(1):303-313, 2009.
7. Abreu SC, Antunes MA, Pelosi P, Morales MM, Rocco PR: Mechanisms of cellular therapy in respiratory diseases. Intensive Care Med 37(9): 1421-1431, 2011.
8. Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, Atienza D, Williams ED, Jenkin G, Wallace E, Trounson A, Manuelpillai U: Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am J Respir Crit Care Med 182(5):643-651, 2010.
9. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100(14):8407-8411, 2003.
10. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33(2):145-152, 2005.
11. Kumamoto M, Nishiwaki T, Matsuo N, Kimura H, Matsushima K: Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. Eur Respir J 34(3):740-748, 2009.
12. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG: Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104(26):11002-11007, 2007.
13. Lee SH, Jang AS, Kim YE, Cha JY, Kim TH, Jung S, Park SK, Lee YK, Won JH, Kim YH, et al.: Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis. Respir Res 11:16, 2010.
14. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4): 663-676, 2006.
15. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448(7151):313-317, 2007.
16. Yang KY, Shih HC, How CK, Chen CY, Hsu HS, Yang CW, Lee YC, Perng RP, Peng CH, Li HY, et al.: IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice. Chest 140(5): 1243-1253, 2011.
17. Li HY, Chien Y, Chen YJ, Chen SF, Chang YL, Chiang CH, Jeng SY, Chang CM, Wang ML, Chen LK, et al.: Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Biomaterials 32(26):5994-6005, 2011.
18. Scotton CJ, Chambers RC: Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132(4):1311-1321, 2007.
19. Njoku DB, Li Z, Mellerson JL, Sharma R, Talor MV, Barat N, Rose NR: IP-10 protects while MIP-2 promotes experimental anesthetic hapten-induced hepatitis. J Autoimmun 32(1):52-59, 2009.
20. Tager AM, Kradin RL, LaCamera P, Bercury SD, Campanella GS, Leary CP, Polosukhin V, Zhao LH, Sakamoto H, Blackwell TS, et al.: Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Am J Respir Cell Mol Biol 31(4):395-404, 2004.
21. Jiang D, Liang J, Campanella GS, Guo R, Yu S, Xie T, Liu N, Jung Y, Homer R, Meltzer EB, et al.: Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest 120(6): 2049-2057, 2010.
22. Bujak M, Dobaczewski M, Gonzalez-Quesada C, Xia Y, Leucker T, Zymek P, Veeranna V, Tager AM, Luster AD, Frangogiannis NG: Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res 105(10):973-983, 2009.
23. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, Farber JM: Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 167(1):399-406, 2001.
24. Shen AS, Haslett C, Feldsien DC, Henson PM, Cherniack RM: The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am Rev Respir Dis 137(3):564-571, 1988.
25. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26(1):101-106, 2008.
26. Masuda S: Risk of teratoma formation after transplantation of induced pluripotent stem cells [author reply 1121]. Chest 141(4):1120-1121, 2012.
27. Engelhardt E, Toksoy A, Goebeler M, Debus S, Brocker EB, Gillitzer R: Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 153(6):1849-1860, 1998.
28. Keane MP, Belperio JA, Arenberg DA, Burdick MD, Xu ZJ, Xue YY, Strieter RM: IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 163(10):5686-5692, 1999.
29. Farber JM: Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61(3):246-257, 1997.
30. Dolhnikoff M, Mauad T, Ludwig MS: Extracellular matrix and oscillatory mechanics of rat lung parenchyma in bleomycin-induced fibrosis. Am J Respir Crit Care Med 160(5 Pt 1):1750-1757, 1999.
31. Horiuchi T, Ikegami M, Cherniack RM, Mason RJ: Increased surface tension of the lung and surfactant in bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 154(4 Pt 1):1002-1005, 1996.
32. Srivastava M, Steinwede K, Kiviranta R, Morko J, Hoymann HG, Langer F, Buhling F, Welte T, Maus UA: Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycininduced pulmonary fibrosis. Respir Res 9:54, 2008.
33. Sueblinvong V, Weiss DJ: Stem cells and cell therapy approaches in lung biology and diseases. Transl Res 156(3):188-205, 2010.